- 9 insiders sold Illumina stock within one month.
- The stock was not purchased by any insiders in the month of intensive selling.
- 2 of these 9 insiders decreased their holdings by more than 10%.
Illumina (NASDAQ:ILMN) develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa.
Insider selling during the last 30 days
Here is a table of Illumina's insider activity during the last 30 days.
|Name||Title||Trade Date||Shares Sold||Option Exercise & Sale||Rule 10b5-1||Current Ownership||Decrease In Ownership|
|Charles Dadswell||SVP||June 27||192||No||Yes||42,749|
|Daniel Bradbury||Director||June 12-27||4,200||Yes||Yes||12,466|
shares + 47,600 options
|Jay Flatley||CEO||June 12-26||60,000||Yes||Yes||387,262 shares + 1,212,812|
|Christian Henry||CCO||June 16-24||30,000||Yes||Yes||28,519|
shares + 102,833 options
|Marc Stapley||CFO||June 16||1,422||Yes||Yes||21,996|
shares + 9,954 options
|Nicholas Naclerio||SVP||June 2-16||62,000||Yes||Yes||23,146|
shares + 68,250 options
|Mostafa Ronaghi||CTO||June 2||10,000||Yes||Yes||28,604|
shares + 144,000 options
|Karin Eastham||Director||June 2||6,000||Yes||Yes||9,826|
shares + 62,700 options
|Michel Bouchard||CAO||June 2||1,491||Yes & No||Yes||24,190|
shares + 5,050 options
There have been 175,305 shares sold by insiders during the last 30 days. All these shares were sold pursuant to a Rule 10b5-1 plan. More details about the Rule 10b5-1 trading plan can be found from this link.
Insider selling by calendar month
Here is a table of Illumina's insider activity by calendar month.
|Month||Insider selling / shares||Insider buying / shares|
There have been 2,253,075 shares sold and there have been zero shares purchased by insiders since January 2013. The month of June has seen the most insider selling this year.
Illumina reported the first-quarter financial results on April 22 with the following highlights:
|GAAP net income||$60.0 million|
The nine insiders sold their shares after these results.
Illumina's 2014 guidance is as follows:
|Qtrly Rev Growth (yoy):||0.27||0.22||-0.00|
|PEG (5 yr expected):||4.16||1.36||2.04|
Illumina has the highest P/S ratio among these three companies.
Here is a table of these competitors' insider activities during the last 30 days.
|Company||Insider buying / shares||Insider selling / shares|
Only Illumina has seen intensive insider selling during the last 30 days.
There have been nine different insiders selling Illumina and there have not been any insiders buying Illumina during the last 30 days. Two of these nine insiders decreased their holdings by more than 10%. Illumina has an insider ownership of 1.34%.
Before going short Illumina, I would like to get a bearish confirmation from the Point & Figure chart. The three main reasons for the proposed short entry are a relatively high P/S ratio, high P/E ratio, and the intensive insider-selling activity.